Cipla sues to invalidate Bristol-Myers’ patents for DVT drug
Intellectual Property 2023-09-20 11:03 pm By Cat Fredenburgh
Please login to bookmark Close

Indian generic drug maker Cipla has sued pharmaceutical giants Bristol-Myers Squibb and Pfizer alleging the patents behind their blockbuster deep vein thrombosis drug Eliquis are invalid.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au